Chen J, Schickel J, Tsakiris N, Sng J, Arbogast F, Bouis D
J Clin Invest. 2021; 132(2).
PMID: 34813502
PMC: 8759783.
DOI: 10.1172/JCI150985.
Jundzill A, Klimczak A, Sonmez E, Brzezicki G, Siemionow M
Arch Immunol Ther Exp (Warsz). 2021; 69(1):28.
PMID: 34633538
PMC: 8505373.
DOI: 10.1007/s00005-021-00631-8.
Hait S, Vargas-Inchaustegui D, Musich T, Mohanram V, Tuero I, Venzon D
J Virol. 2018; 93(4).
PMID: 30463978
PMC: 6364015.
DOI: 10.1128/JVI.01687-18.
Amodio D, Cotugno N, Macchiarulo G, Rocca S, Dimopoulos Y, Castrucci M
J Immunol. 2017; 200(2):538-550.
PMID: 29237774
PMC: 5760299.
DOI: 10.4049/jimmunol.1701312.
Pierini A, Nishikii H, Baker J, Kimura T, Kwon H, Pan Y
Nat Commun. 2017; 8:15068.
PMID: 28485401
PMC: 5436085.
DOI: 10.1038/ncomms15068.
Antiallergic Function of KR62980, a Peroxisome Proliferator-Activated Receptor-γ Agonist, in a Mouse Allergic Rhinitis Model.
Lee J, Zhang Y, Han D, Kim D, Rhee C
Allergy Asthma Immunol Res. 2015; 7(3):256-64.
PMID: 25749778
PMC: 4397366.
DOI: 10.4168/aair.2015.7.3.256.
The Serine Protease Inhibitor, 4-(2-aminoethyl) Benzene Sulfonyl Fluoride Hydrochloride, Reduces Allergic Inflammation in a House Dust Mite Allergic Rhinitis Mouse Model.
Kim B, Park H, Shin J, Kim S, Cho J, Park Y
Allergy Asthma Immunol Res. 2014; 6(6):558-66.
PMID: 25374756
PMC: 4214977.
DOI: 10.4168/aair.2014.6.6.558.
B cells are critical for autoimmune pathology in Scurfy mice.
Aschermann S, Lehmann C, Mihai S, Schett G, Dudziak D, Nimmerjahn F
Proc Natl Acad Sci U S A. 2013; 110(47):19042-7.
PMID: 24194550
PMC: 3839754.
DOI: 10.1073/pnas.1313547110.
Effect of chronic morphine administration on circulating T cell population dynamics in rhesus macaques.
Cornwell W, Lewis M, Fan X, Rappaport J, Rogers T
J Neuroimmunol. 2013; 265(1-2):43-50.
PMID: 24090653
PMC: 3852163.
DOI: 10.1016/j.jneuroim.2013.09.013.
T follicular helper cell diversity and plasticity.
Cannons J, Lu K, Schwartzberg P
Trends Immunol. 2013; 34(5):200-7.
PMID: 23395212
PMC: 3646926.
DOI: 10.1016/j.it.2013.01.001.
Amelioration of arthritis through mobilization of peptide-specific CD8+ regulatory T cells.
Leavenworth J, Tang X, Kim H, Wang X, Cantor H
J Clin Invest. 2013; 123(3):1382-9.
PMID: 23376792
PMC: 3582146.
DOI: 10.1172/JCI66938.
Regulatory T cells use programmed death 1 ligands to directly suppress autoreactive B cells in vivo.
Gotot J, Gottschalk C, Leopold S, Knolle P, Yagita H, Kurts C
Proc Natl Acad Sci U S A. 2012; 109(26):10468-73.
PMID: 22689978
PMC: 3387068.
DOI: 10.1073/pnas.1201131109.
Foxp3+ follicular regulatory T cells control the germinal center response.
Linterman M, Pierson W, Lee S, Kallies A, Kawamoto S, Rayner T
Nat Med. 2011; 17(8):975-82.
PMID: 21785433
PMC: 3182542.
DOI: 10.1038/nm.2425.
T regulatory cells participate in the control of germinal centre reactions.
Alexander C, Tygrett L, Boyden A, Wolniak K, Legge K, Waldschmidt T
Immunology. 2011; 133(4):452-68.
PMID: 21635248
PMC: 3143357.
DOI: 10.1111/j.1365-2567.2011.03456.x.
An alphavirus vector overcomes the presence of neutralizing antibodies and elevated numbers of Tregs to induce immune responses in humans with advanced cancer.
Morse M, Hobeika A, Osada T, Berglund P, Hubby B, Negri S
J Clin Invest. 2010; 120(9):3234-41.
PMID: 20679728
PMC: 2929723.
DOI: 10.1172/JCI42672.
CCR6 recruits regulatory T cells and Th17 cells to the kidney in glomerulonephritis.
Turner J, Paust H, Steinmetz O, Peters A, Riedel J, Erhardt A
J Am Soc Nephrol. 2010; 21(6):974-85.
PMID: 20299360
PMC: 2900961.
DOI: 10.1681/ASN.2009070741.
ICOS expression by effector T cells influences the ability of regulatory T cells to inhibit anti-chromatin B cell responses in recipient mice.
Hondowicz B, Batheja A, Metzgar M, Caton A, Erikson J
J Autoimmun. 2009; 34(4):460-8.
PMID: 20022728
PMC: 2859982.
DOI: 10.1016/j.jaut.2009.11.016.
Regulatory T cells and immune tolerance to coagulation factor IX in the context of intramuscular AAV1 gene transfer.
Kelly M, Bharadwaj A, Tacke F, Chao H
Mol Ther. 2009; 18(2):361-9.
PMID: 19935782
PMC: 2839290.
DOI: 10.1038/mt.2009.269.
Efficient help for autoreactive B-cell activation requires CD4+ T-cell recognition of an agonist peptide at the effector stage.
Hondowicz B, Batheja A, Metzgar M, Pagan A, Perng O, Willms S
Eur J Immunol. 2009; 39(9):2377-82.
PMID: 19662636
PMC: 3015147.
DOI: 10.1002/eji.200939471.
Surveillance of antigen-presenting cells by CD4+ CD25+ regulatory T cells in autoimmunity: immunopathogenesis and therapeutic implications.
Andre S, Tough D, Lacroix-Desmazes S, Kaveri S, Bayry J
Am J Pathol. 2009; 174(5):1575-87.
PMID: 19349365
PMC: 2671245.
DOI: 10.2353/ajpath.2009.080987.